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Abstract
Objective To determine inter-observer and inter-examination
variability of manual attenuationmeasurements of the vertebrae
in low-dose unenhanced chest computed tomography (CT).
Methods Three hundred and sixty-seven lung cancer screen-
ing trial participants who underwent baseline and repeat
unenhanced low-dose CT after 3 months because of an inde-
terminate lung nodule were included. The CT attenuation val-
ue of the first lumbar vertebrae (L1) was measured in all CTs
by one observer to obtain inter-examination reliability. Six
observers performed measurements in 100 randomly selected
CTs to determine agreement with limits of agreement and
Bland-Altman plots and reliability with intraclass correlation
coefficients (ICCs). Reclassification analyses were performed
using a threshold of 110 HU to define osteoporosis.
Results Inter-examination reliability was excellent with an ICC
of 0.92 (p<0.001). Inter-examination limits of agreement ranged
from -26 to 28 HU with a mean difference of 1±14 HU. Inter-
observer reliability ICCs ranged from 0.70 to 0.91. Inter-
examination variability led to 11.2 % reclassification of partici-
pants and inter-observer variability led to 22.1 % reclassification.
Conclusions Vertebral attenuation values can be manually
quantified with good to excellent inter-examination and
inter-observer reliability on unenhanced low-dose chest CT.
This information is valuable for early detection of osteoporo-
sis on low-dose chest CT.
Key Points
• Vertebral attenuation values can be manually quantified on
low-dose unenhanced CT reliably.
• Vertebral attenuation measurements may be helpful in de-
tecting subclinical low bone density.
• This could become of importance in the detection of
osteoporosis.
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Abbreviations
BMD Bone mineral density
BMI Body mass index
CT Computed tomography
DXA Dual-energy x-ray absorptiometry
HU Hounsfield unit
ICC Intraclass correlation coefficient
L1 First lumbar vertebral body
QCT Quantitative computed tomography
ROI Region of interest
SD Standard deviation
T12 12th thoracic vertebral body
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Introduction
Osteoporosis is a worldwide health problem contributing con-
siderably to health care costs, morbidity and mortality [1].
Due to the increasing age of the population, this problem will
become even more substantial over time. Osteoporosis is a
good candidate for screening, because it has a long preclinical
phase and cost-effective therapeutic possibilities are readily
available [2]. Therefore, early detection may be a reasonable
strategy to prevent osteoporosis related fractures [3].
Bone mineral density (BMD) can be derived from quanti-
tative computed tomography (QCT), ultrasound, and dual en-
ergy x-ray absorptiometry (DXA), but the World Health Or-
ganization (WHO) definition for osteoporosis only includes
the DXAT-score [4]. DXA is a strong predictor of bone dete-
rioration and fracture risk [5]. Nevertheless, osteoporosis re-
mains underdiagnosed in the general population [6]. Recent
studies proposed the use of regular clinical computed tomog-
raphy (CT)-scans for bone mineral density assessment as an
opportunistic screening method [7–14]. In this way, BMD
surrogates could be derived from CTwithout additional radi-
ation dose. Deterioration of BMD could be determined in the
early stages of disease, which could prompt suitable medical
treatment of osteoporosis, and thus prevent fractures in pa-
tients at risk. Additionally, scans performed in screening pro-
grams such as lung cancer screening or coronary artery dis-
ease evaluation may also be used, since BMD measurements
on CT have been shown to predict all-cause mortality in lung
cancer screening participants [15].
Bone density measurements on CTare mostly performed by
manually placing a region of interest (ROI) in a lumbar or
thoracic vertebra. Although in the future ROI measurements
may possibly be executed automatically using software, the
placement of a ROI is currently performed manually, and thus
may vary in size, shape and location [16]. This could introduce
variability in measurements and may depend on the experience
of the observer. Furthermore, the inter-examination reliability is
currently unknown. High inter-examination reliability would
enable monitoring changes over time; for example, after an
intervention. A few studies addressed the reproducibility of
bone density assessment of the vertebrae [9, 17], but data is
missing for unenhanced low-dose thoracic CT. Therefore, the
aim of this study was to assess the inter-observer and inter-
examination reliability and agreement in attenuation measure-
ments of the vertebrae on low-dose unenhanced CT.
Materials and methods
Subjects
The study population was derived from the Dutch and
Belgian Lung Cancer Screening Trial (NELSON). For
this study, subjects from the University Medical Center
Utrecht were included. A detailed description of study
rationale and design is published elsewhere [18, 19]. In
short, current and former smokers aged 50–75 years were
included. Included participants had a smoking history of
>15 cigarettes/day during >25 years or >10 cigarettes/
day during >30 years. The NELSON trial was approved
by the Dutch Ministry of Health and the local institution-
al ethical review board. Written informed consent was
obtained for all participants. Participants who underwent
a short-term follow-up CT after 3 months because of an
intermediate risk lung nodule were included. Participants
were excluded if the scan protocol, especially the kilo-
Voltage, differed between baseline and follow-up, or
when the interval between the CTs was longer than
100 days.
Image acquisition
All participants underwent a low-dose inspiratory volumetric
CT scan using a 16-slice scanner (Brilliance 16P or MX8000
IDT; Philips Healthcare, Best, The Netherlands). The same
scanning protocols were used at baseline and follow-up in
the subjects included in this study. CT data were obtained
using 16×0.75 mm collimation (pitch=1.3) [20]. No intrave-
nous contrast injection was applied. Participants weighing less
than 80 kg were scanned with 120 kVp at 30 mAs. Partici-
pants weighing 80 kg or more were scanned with 140 kVp at
30 mAs. Slice thickness was 1.0 mm and axial images were
reconstructed at 0.7 mm increment, using a smooth recon-
struction filter (B-filter; Philips Healthcare, Best,
The Netherlands). The scanners were calibrated according to
the manufacturers recommendations and screening scans were
obtained within 24 hours after calibration.
Assessment of BMD – ROI placement
Before measurements were made, all observers attended an
interactive training session to become skilful in the measure-
ment technique. First, observers were instructed to evaluate
the first lumbar vertebral body (L1) for the presence of frac-
tures and focal heterogeneities. Secondly, the upper part of L1
was identified by defining the area between the endplate and
the entrance of vessels at the midportion. Thirdly, a rectangu-
lar ROI was as large as possible and positioned in a homoge-
nous area of trabecular bone, without inclusion of the cortex
and inhomogeneous areas. All measurements were performed
in axial view. The mean CT attenuation was measured in
Hounsfield Units (HU). An example is given in Fig. 1. If L1
was fractured, inhomogeneous or not visualized, the first in-
tact vertebra from L1 upwards was measured. For instance, if
L1 was fractured, the twelfth thoracic vertebra (T12) was
used.
Eur Radiol (2016) 26:3046–3053 3047
Image analysis
Six observers with various levels of experience in CT reading
participated in the current study: one board certified chest
radiologist with 10 years of experience (P.J.), one board certi-
fied radiologist with 8 years of experience (R.B.), three re-
search physicians with 2 years of experience (R.T., M.W.
and E.P.) in CT reading and one medical student (W.J.).
To obtain inter-observer agreement, all six observers per-
formed ROI measurements in 100 randomly selected CT
scans. Measurements were conducted independently by all
observers without knowledge of the outcomes of the other
observers. For the inter-examination reliability and agreement,
one observer (E.P.), who showed good agreement with the
experienced observers, examined all baseline and follow-up
CTs. Measurements at follow-up scans were made in the same
session as the baseline scans. All scans were measured in a
random order and the reader was blinded for acquisition date.
Measurements were made at the same vertebral level for base-
line and follow-up. If measurements in L1 were not feasible
because of inhomogeneous areas or was not included on CT,
the first intact vertebra fromL1 upwards wasmeasured both at
baseline and at follow-up. Observers performed measure-
ments in bone window (C: 300; W: 1600) and were blinded
for subject characteristics.
Statistical analysis
Inter-examination reliability was assessed using the single
measures intraclass correlation coefficient (ICC). ICCs were
compared using a student t-test. The limits of inter-
examination agreement were defined as the mean difference
±1.96× the standard deviation (SD) and was plotted using the
Bland-Altman method [21].
Inter-observer reliability was estimated for all measure-
ments made in 100 participants, using the single measures
ICC. Inter-observer agreement was calculated using the mean
difference ± SD and was assessed by a graphical method pro-
posed by Jones et al. [22] This method is based on the Bland-
Altman graphical method for the assessment of agreement
between two observers, and is modified to allow for agree-
ment between multiple observers. The limits of agreement
from the mean represent how different a measurement of an
individual observer can be compared with the mean measure-
ment of all observers.
In addition, the effect of inter-examination variability or
inter-observer variability on reclassification of patients as os-
teoporotic versus non-osteoporotic based on previously sug-
gested cutoffs was calculated. To define osteoporosis a thresh-
old of 110 HU was used, as derived from Pickhardt et al. [7]
All analyses were performed using SPSS Version 20.0 (SPSS,
Chicago, Illinois, USA). P values below 0.05 were considered




In total, 539 participants were rescanned after 3 months be-
cause of an indeterminate lung nodule. One hundred randomly
selected scans were selected for inter-observer analysis. For
inter-examination analysis, 97 participants were excluded be-
cause of the use of a different kVp at baseline and follow-up.
Another 75 participants were excluded because of a follow-up
time of more than 100 days; this resulted in 367 eligible par-
ticipants for inter-examination analysis. A flowchart of in- and
exclusion of participants is shown in Fig. 2. Mean ± SD age
was 60.6 ± 5.9 years. Median time between the baseline and
follow-up CT was 91 (P25 – P75: 91 – 91) days. Additional
baseline characteristics are presented in Table 1.
Inter-examination variability
287 (78.2 %) measurements were made at level L1, 69
(18.8 %) at level T12, 10 (2.7 %) at level T11 and 1 (0.3 %)
at level T10. Mean ± SD bone density was 108 ± 35 HU at
baseline and 107 ± 35HU at follow-up. The inter-examination
agreement for ROI measurements of 367 participants was ex-
cellent with an ICC of 0.92 (0.90 – 0.94, p < 0.01) and did not
differ significantly between men and women (0.92 (0.91-0.94)
vs. 0.94 (0.90-0.96)). Inter-examination ICCs did not differ
significantly between vertebral levels with an ICC for L1 of
0.92 (0.90–0.94), an ICC for T12 of 0.91 (0.86–0.95) and an
ICC for T11 of 0.92 (0.72–0.98). Mean ± SD difference be-
tween baseline and follow-up was 1 ± 14 HU. The inter-
100 HU
Fig. 1 Example of placement of region of interest (ROI) in the first
lumbar vertebra (L1) of a participant. Axial image of L1 in bone window
(C: 300; W: 1600). A ROI is placed in the upper part of L1 between the
endplate and the entrance of vessels at the midportion. The ROI was as
large as possible and positioned in a homogenous area without inclusion
of the cortex
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examination agreement is plotted in Fig. 3. Limits of agree-
ment were -26 and 28 HU.
Inter-observer variability
Eleven (1.8 %) measurements were missing due to software
problems. For this reason, multiple imputations were used to
complete the data set (20 imputations). Of all measurements,
the mean ± SD HU-value was 100 ± 28 HU.Mean HU-values
for all observers ranged from 95 to 105 HU, with SD ranging
from 28 to 33 HU. Overall inter-observer reliability for mea-
suring HU-attenuation of the vertebrae was excellent, with an
ICC of 0.82 (p<0.001). All ICCs compared between two
observers are shown in Table 2 and varied from moderate
(0.70) to excellent (0.91). The mean difference ± SD between
all observers was 1 ± 6 HU. The inter-observer agreement of
all 100 examinations is plotted in Fig. 4. Limits of agreement
with the mean ranged from -12 to 12 HU.
Reclassification analysis
For reclassification analyses, only measurements at L1 were
used (n=287). Based on a threshold of 110 HU, 159 (55.4 %)
participants were classified as having osteoporosis at baseline
and 163 (56.8 %) participants at follow-up. Fourteen (4.9 %)
participants were classified as having osteoporosis at baseline,
but not at follow-up, and 18 (6.3 %) participants were classi-
fied as having osteoporosis at follow-up, but not at baseline.
Table 3 shows reclassification results due to inter-examination
variation.
When using the same threshold of 110 HU to define oste-
oporosis in 77 participants with inter-observer measurements
at L1, all six observers agreed about the diagnosis (osteopo-
rosis yes/no) in 60 (77.9 %) participants and at least one ob-
server did not agree in 17 (22.1 %) participants.
Discussion
In this study, we found excellent inter-examination reliability
for manual bone density measurements of the vertebrae.
Limits of agreement ranged from -26 to 28 HU, which means
a change of at least 28 HU is needed in order to detect a real
change in bone attenuation. Therefore, these results have to be
taken into account when planning to use bone density mea-
surements for longitudinal studies (e.g., for measuring thera-
peutic effects). Inter-observer reliability was good to excellent
and limits of agreement with the mean ranged from -12 to 12
HU, which indicates that observers can be discordant with the
mean estimated bone attenuation by 12 HU.
Our results imply that manual placement of a ROI in L1 is a
reliable method for the quantification of vertebral attenuation.
Therefore, in a lung cancer screening setting, low-dose chest
CTs may be used to measure bone attenuation. Because these
Participants with baseline and follow-up chest CT scan
    n = 539
Identical scan protocol at 
baseline and follow-up 
     n = 442
Eligible for inter-examination 
analysis
        n = 367
Different scan protocol at 
baseline and follow-up
      n = 97
Follow-up time > 100 days
       n = 75
Baseline or follow-up scans for 
inter-observer analysis
          n = 100 
Fig. 2 Flow-chart of in- and
exclusion of participants







Age (years), mean ± SD 60.6 ± 5.9






Median (25th percentile – 75th percentile)
38.7 (29.7–53.2)
SD: standard deviation; HU: Hounsfield Unit
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measurements are performed manually, in theory, experience
could influence the precision of the measurement. However,
the present study shows that radiological experience has no
major effect on attenuation measurements. Moreover, ICCs
between more experienced observers were not better than be-
tween less experienced observers. Low-dose CT scans could
therefore gain a role in early detection of osteoporosis.
With the recent recommendation on the implementation of
lung cancer screening [24], a large number of subjects will
receive a low-dose chest CT. Next to screening for lung can-
cer, this can provide an opportunity for the assessment of other
abnormalities, such as chronic obstructive pulmonary disease
and coronary artery calcifications [25]. Because smoking is
associated with lower bone density [26], this could be an
opportunity for the detection of osteoporosis in this smoking
population. By diagnosing low bone density as well, this
could improve the yield and cost-effectiveness of lung cancer
screening.
To our knowledge, this is the first study to describe the
inter-examination agreement and reliability of attenuation
measurements of the vertebrae on unenhanced low-dose CT
in a large population. In addition, we extensively studied inter-
observer agreement and reliability. Although several studies
used attenuation measurements in the search for an appropri-
ate screening tool for osteoporosis, studies on the agreement
and reliability are lacking.
Ohara et al. [9] studied the correlation between pulmonary
emphysema and reduced bone density. For this purpose, they
used manual vertebral bone measurements. They validated
their measurements by calculating correlation coefficients of
two observers. This resulted in ICCs of 0.995, 0.993, 0.950
and 0.996 for T4, T7, T10 and L1, respectively. Their strength
was the evaluation of multiple vertebral levels, but they con-
cluded that the average bone density of three thoracic vertebral
bones was highly correlated with bone density in L1 alone
(r=0.914, p<0.001). Pickhardt et al. [7] elaborated on this
and found that measurements at L1 are as or more accurate
than the results at other levels, includingmultilevel assessment.
Also, Romme et al. [27] showed no added value of using three
thoracic vertebral levels to assess bone density compared to



















shown for 367 participants. The
mean of differences (solid
horizontal line) was 1 HU. The
upper dashed line shows the
upper 95% limit of agreement (28
HU), and the bottom dashed line
shows the lower 95 % limit of
agreement (-26 HU)
Table 2 Inter-observer agreement for ROI measurements
Observer 1
Observer 2 0.87 Observer 2
Observer 3 0.76 0.70 Observer 3
Observer 4 0.91 0.87 0.73 Observer 4
Observer 5 0.86 0.86 0.70 0.87 Observer 5
Observer 6 0.89 0.88 0.75 0.89 0.88
Data given are intraclass correlation coefficients. All correlation coeffi-
cients were significantly correlated (p< 0.001).
ROI: region of interest
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most accurate results in terms of attenuation measurements,
this vertebral level is not always included on thoracic CT. In
our population of 376 participants, 89 (23.7 %) measurements
were made at a vertebral level different from L1.
Both Pickhardt et al. [17] and Romme et al. [27] studied
inter-observer agreement and found limits of agreement between
two observers of -6 HU to 16 HU for T12-L5 and -9 to 5 HU for
T4-T7-T10, respectively. We complemented to this by using six
observers with different experience levels and showed limits of
agreement with the mean ranging from -12 to 12 HU. The intra-
observer limits of agreement from Romme et al. ranged from -9
to 5 HU in 20 participants. Our limits of agreement were sub-
stantially wider, ranging from -26 to 28 HU, but could be more
realistic as a result of a larger study cohort.
Next to presenting positive results in terms of agreement
and reliability, it is important to estimate the impact of these
results on clinical practice. In order to perform reclassification
analyses, we used a threshold of 110 HU to define osteoporo-
sis, which was derived from Pickhardt et al [7]. This threshold
was proposed for a routine care population with lower osteo-
porosis risk because of its high specificity. Buckens et al. [28]
validated this threshold as being the most optimal as compared
to DXA. By using this threshold, 159 (55.4 %) participants
were classified as having osteoporosis. This high prevalence is
in line with some findings of osteoporosis prevalence in a
high-risk chronic obstructive pulmonary disease (COPD) co-
hort [29].With this heavy smoking population being at risk for
osteoporosis as well, these prevalence numbers could be ap-
propriate. Another explanation for the high prevalence could
be that the HU in the vertebra was systematically lower com-
pared to the study by Pickhardt and Buckens.
Our reclassification analysis showed that inter-examination
variability can lead to a different diagnosis in 11.2 % of in-
cluded participants. Moreover, variability of inter-observer
measurements can lead up to 22.1 % misclassified partici-
pants. As a consequence, when measuring bone density that
is close to a threshold that defines disease, the effect of vari-

























Fig. 4 Inter-observer agreement
plot between six observers for
vertebral attenuation
measurements. Observers
represent different symbols. The
differences of all measurements
with the mean (y-axis) are plotted
against the mean Hounsfield unit
(HU) values for all participants
(x-axis). The horizontal dashed
lines indicate the limits of
agreement with the mean of the
six observers and ranged from -12
to 12 HU. This could indicate that
the observers can be discordant
with the mean BMD by as much
as 12 HU




No (n) Yes (n) Total
<110HU at baseline No (n) 110 (38.3 %) 18 (6.3 %) 128 (44.6 %)
Yes (n) 14 (4.9 %) 145 (50.5 %) 159 (55.4 %)
Total 124 (43.2 %) 163 (56.8 %) 287 (100 %)
Reclassification of participants with a threshold of 110 HU according to inter-examination variability
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be substantial. Considering the development of guidelines for
osteoporosis screening, variability consequently has to be tak-
en into account.
Our study has limitations. First, the follow-up scans for the
assessment of inter-examination variability were performed
three months after baseline. In this period, CT attenuation
values could have altered. However, we think the impact will
be limited because decline in bone density progresses slowly.
Still, a follow-up CTexamination directly after baseline would
bemore ideal to eliminate changes over time. Second, we only
used measurements of one vertebra in our evaluation and did
not include more vertebral levels. Nevertheless, one may as-
sume that, even if bone attenuation may vary at each vertebral
level, inter-observer and inter-examination agreement may be
similar [9]. Thereby, former studies have shown that ROI
placement in multiple vertebrae does not add value compared
to one measurement at L1 [7, 27]. Third, as a consequence
from the study design of the lung cancer screening trial, only a
small amount of our cohort consisted of women. But, in this
cohort, no difference was seen in inter-examination differ-
ences in HU between men and women. Lastly, although our
scanners were calibrated weekly, we did not use a calibration
phantom in this study as is done in QCTof the spine. We were
therefore unable to provide BMD as milligrams hydroxyapa-
tite per cubic centimetre and our method has lower precision
compared to QCT [30, 31]. However, previous studies have
shown that, although precision was lower compared to QCT,
BMD estimation techniques without phantom calibration
were nevertheless promising for assessing fracture risk [11].
In conclusion, this study shows that bone attenuation can
be measured by manual ROI placement on unenhanced low-
dose chest CT examinations with good reliability. However,
when developing guidelines for early detection of osteoporo-
sis, variability still has to be taken into account. While the
distinctive character of this technique is excellent, diagnostic
studies are needed to confirm these results, to evaluate its
accuracy and ultimately its cost-effectiveness.
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